Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 8363

I interviewed Aubrey de Grey from the SENS Research Foundation about the fight to eliminate ageing in humans, why he believes the first 1,500 year old human has probably been born and the transhumanist movement. Trying to grow the channel (on futurism/transhumanism) so please do sub if this is of interest.

I interview biologist Aubrey de Grey, Chief Science Officer of the SENS Research Foundation, about whether humans can overcome ageing (and therefore theoretically live for thousands of years). We discuss the obstacles to ending ageing, whether the first 1,500 year old human is currently alive and the transhumanist movement. Oh and I say longitudinal rather than longevity escape velocity which was a little embarrassing!

Aubrey is also VP of New Technology Discovery at AgeX Therapeutics and author of ‘Ending Aging’.

Continue reading “Can humans defeat ageing? Aubrey de Grey interview” | >

Scientists at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have made a surprising discovery that could help explain our risk for developing chronic diseases or cancers as we get older, and how our food decomposes over time.

What’s more, their findings, which were reported recently in the Proceedings of the National Academy of Sciences (PNAS), point to an unexpected link between the ozone chemistry in our atmosphere and our cells’ hardwired ability to ward off disease.

“The beauty of nature is that it often decides to use similar chemistries throughout a system, but we never thought that we would find a common link between atmospheric chemistry, and the chemistry of our bodies and food,” said Kevin Wilson, the deputy director of Berkeley Lab’s Chemical Sciences Division who led the study. “Our study is the first to explore another chemical pathway that might affect how well the cells in our bodies — and even our food — can respond to oxidative stress, such as pollution, over time.”

Read more | >

The coronavirus outbreak is bringing attention to the fast-growing vaccine industry.

The vaccine market has grown sixfold over the past two decades, worth more than $35 billion today, according to AB Bernstein. The firm said the industry has consolidated to four big players that account for about 85% of the market — British drugmaker GlaxoSmithKline, French pharmaceutical company Sanofi, and U.S.-based Merck and Pfizer.

“For every dollar invested in vaccination in the world’s 94 lowest-income countries, the net return is $44. Hard to argue against,” Wimal Kapadia, Bernstein’s analyst, said in a note. “This oligopoly has been built through significant market consolidation driven primarily by the complexities of the manufacturing and supply chain.”

Read more | >

While robotics and automation create a plethora of opportunities for skilled labor, they substitute many jobs of unskilled labor. Philips’ automated shaver factory in the Netherlands employs one-tenth of the workforce of its factory in China that makes the same shavers. Such developments accentuate inequality and pose severe social pressure in developed countries, which would need to be addressed by government in the years to come.

Technology can complement humans but it can also eliminate their jobs.

Lilac Nachum

Read more | >